SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 12/19/2025 at 20:21, 10 months 13 days ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 10 months 16 days ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
BRIEF

published on 12/17/2025 at 07:35, 10 months 16 days ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
PRESS RELEASE

published on 12/17/2025 at 07:30, 10 months 16 days ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 10 months 18 days ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF

published on 12/15/2025 at 07:10, 10 months 18 days ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
PRESS RELEASE

published on 12/15/2025 at 07:05, 10 months 18 days ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 10 months 18 days ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 10 months 18 days ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 10 months 22 days ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi

Published on 11/02/2026 at 14:00, 5 minutes ago

GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Published on 11/02/2026 at 13:30, 35 minutes ago

Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
Published on 11/02/2026 at 13:30, 35 minutes ago

Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
Published on 11/02/2026 at 13:00, 1 hour 5 minutes ago

International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 11/02/2026 at 13:00, 1 hour 5 minutes ago

Bocana Resources Corp. provides an Update on the Proposed Transaction with London Gold LLC

View all ACCESSWIRE

Published on 11/02/2026 at 13:56, 9 minutes ago

Total Voting Rights
Published on 11/02/2026 at 13:22, 43 minutes ago

Pillar 3 Report as at 30 September 2026
Published on 11/02/2026 at 13:21, 44 minutes ago

Westpac 2026 Sustainability Report
Published on 11/02/2026 at 13:20, 45 minutes ago

Westpac 2026 Presentation and Investor Discussion Pack
Published on 11/02/2026 at 13:19, 46 minutes ago

Westpac 2026 Full Year Results email to shareholders

View all EQS

Published on 10/30/2026 at 23:00, 2 days 15 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 17 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 20 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days 2 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 3 days 5 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News